Source: Diabetology & Metabolic Syndrome. Unidade: FSP
Subjects: DIABETES MELLITUS, SINERGISMO DE DROGAS, INFLAMAÇÃO, LIPÍDEOS (EFEITOS DE DROGAS), ESTADO PRÉ-DIABÉTICO (QUIMIOTERAPIA;PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KATER, Ana Lucia de Almeida e BATISTA, Marcelo C. e VIVOLO, Sandra Roberta Gouvea Ferreira. Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects. Diabetology & Metabolic Syndrome, p. 1-7, 2010Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-2-34. Acesso em: 04 out. 2024.APA
Kater, A. L. de A., Batista, M. C., & Vivolo, S. R. G. F. (2010). Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects. Diabetology & Metabolic Syndrome, 1-7. doi:10.1186/1758-5996-2-34NLM
Kater AL de A, Batista MC, Vivolo SRGF. Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects [Internet]. Diabetology & Metabolic Syndrome. 2010 ; 1-7.[citado 2024 out. 04 ] Available from: https://doi.org/10.1186/1758-5996-2-34Vancouver
Kater AL de A, Batista MC, Vivolo SRGF. Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects [Internet]. Diabetology & Metabolic Syndrome. 2010 ; 1-7.[citado 2024 out. 04 ] Available from: https://doi.org/10.1186/1758-5996-2-34